Viridian Therapeutics, Inc. earnings per share and revenue

VRDN earnings per share for the last quarter are -0.81 USD whereas the estimation was -1.04 USD which accounts for 21.76% surprise. Company revenue for the same period amounts to 72.00 k USD despite the estimated figure of 44.00 k USD. Estimated earnings per share for the next quarter are -0.97 USD, and revenue is expected to reach 52.09 k USD. Also watch annual changes over time to get a bigger picture of VRDN earnings per share and revenue dynamics.